← Scoopfeeds — Intelligent news, curated.
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
top

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

The Guardian · Jun 18, 2026, 12:45 PM · Also reported by 1 other source

Why this matters: a developing story that could shape the day's news cycle.

Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older US health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the Covid-19 pandemic. Moderna is seeking Food and Drug Administration (FDA) approv

Read full story on The Guardian → More top stories

Also covered by

The Hill FDA vaccine panel set to review Moderna mRNA flu shot

More in top

The Guardian
The CGT ‘backflip’ is more tweak than transformation. Labor hasn’t changed its mind on housing
The Guardian
Australian net overseas migration falls to lowest level since 2022 – but the Coalition says that’s still too high
The Guardian
Wiltshire village exhibits Martin Parr’s final photos of scarecrows and prize veg
The Guardian
Dancing to artefacts: London Museum will be ‘democratic’ space for all, says director
NPR News
The head of the family is 17. Money is tight. The roof leaks. How did this happen?
Aggregated and edited by the Scoop newsroom. We surface news from The Guardian alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop